ZAFIRLUKAST CHEMBL603 cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate BDBM50009073 cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate 4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide
- Schierle, S; Flauaus, C; Heitel, P; Willems, S; Schmidt, J; Kaiser, A; Weizel, L; Goebel, T; Kahnt, AS; Geisslinger, G; Steinhilber, D; Wurglics, M; Rovati, GE; Schmidtko, A; Proschak, E; Merk, D Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology. J Med Chem 61: 5758-5764 (2018)
- Brown, MF; Marfat, A; Antognoli, G; Chambers, RJ; Cheng, JB; Damon, DB; Liston, TE; McGlynn, MA; O'Sullivan, SP; Owens, BS; Pillar, JS; Shirley, JT; Watson, JW N-carbamoyl analogs of Zafirlukast: potent receptor antagonists of leukotriene D4. Bioorg Med Chem Lett 8: 2451-6 (1999)